Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03112265 · ClinicalTrials.gov registry record · NA

Using Neuroimaging to Understand Children's Mental Health and Treatment Outcomes

A NA study of Depression and Anxiety, sponsored by Harvard University.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT03112265: Completed NA study of Depression and Anxiety, sponsored by Harvard University.

NCT03112265 is a NA study of Depression and Anxiety that has completed, run by Harvard University. The registered enrollment target is 100 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03112265, a NA study of Depression and Anxiety, has completed, sponsored by Harvard University.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The study will compare the impact of Child STEPs versus usual school-based therapy on neural and companion behavioral measures of self-regulation.

Interventions

  • BEHAVIORAL Treatment as usual
  • BEHAVIORAL Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, and Conduct Problems
  • OTHER Monitoring and Feedback System

Study Locations (1)

Massachusetts

  • Harvard University - Cambridge

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2015-01
Est. Completion 2020-07-31
Phase NA
Harvard University

37 total trials

What the finished NCT03112265 record still lists

NCT03112265 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower).

The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Treatment as usual is the first listed.

NCT03112265 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03112265 about?

NCT03112265 is a clinical study titled "Using Neuroimaging to Understand Children's Mental Health and Treatment Outcomes". The study will compare the impact of Child STEPs versus usual school-based therapy on neural and companion behavioral measures of self-regulation.

What is the current status of trial NCT03112265?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-01. Estimated completion is 2020-07-31.

What conditions does trial NCT03112265 study?

This clinical trial studies the following conditions: Depression, Anxiety, Trauma, Behavior Problems.

What interventions are being tested in trial NCT03112265?

The interventions under investigation include: Treatment as usual (BEHAVIORAL), Modular Approach to Therapy for Children with Anxiety, Depression, Trauma, and Conduct Problems (BEHAVIORAL), Monitoring and Feedback System (OTHER).

Who is sponsoring clinical trial NCT03112265?

This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03112265 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03112265's enrollment target sits among peer trials

100 326th of 679 higher than 331 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03112265, the US trial registry maintained by the National Library of Medicine. NCT03112265 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.